Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing. more
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -0.92% | 0.77% |
| 1-Month Return | 12.84% | 3% |
| 3-Month Return | 25.39% | 1.43% |
| 6-Month Return | 25.33% | 12.03% |
| 1-Year Return | 53.75% | 20.13% |
| 3-Year Return | 99.85% | 70.9% |
| 5-Year Return | 101.6% | 70.4% |
| 10-Year Return | 250.5% | 254.47% |
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -38.24% | 49.18% |
| 1-Month Return | 334.81% | 43.28% |
| 3-Month Return | 150.33% | 5.93% |
| 6-Month Return | 58.06% | 25.90% |
| 1-Year Return | 53.75% | 20.13% |
| 3-Year Return | 25.96% | 19.56% |
| 5-Year Return | 15.05% | 11.25% |
| 10-Year Return | 13.36% | 13.49% |
| Stock name | Ticker | Weight |
|---|---|---|
Moderna Inc | MRNA | 3.48% |
Omeros Corp | OMER | 2.68% |
Iovance Biotherapeutics Inc | IOVA | 2.47% |
Verastem Inc | VSTM | 2.22% |
Precigen Inc | PGEN | 1.97% |
Zai Lab Ltd | ZLAB | 1.92% |
Halozyme Therapeutics Inc | HALO | 1.91% |
Kiniksa Pharmaceuticals International Plc | KNSA | 1.89% |
Rigel Pharmaceuticals Inc | RIGL | 1.78% |
Kura Oncology Inc | KURA | 1.76% |
BeOne Medicines Ltd | BGNE | 1.75% |
ACADIA Pharmaceuticals Inc | ACAD | 1.74% |
Sarepta Therapeutics Inc | SRPT | 1.71% |
Nuvation Bio Inc | NUVB | 1.7% |
Protagonist Therapeutics Inc | PTGX | 1.65% |
Geron Corp | GERN | 1.65% |
Regeneron Pharmaceuticals Inc | REGN | 1.63% |
Immunocore Holdings PLC | IMCR | 1.59% |
Travere Therapeutics Inc | TVTX | 1.59% |
Xeris Biopharma Holdings Inc | XERS | 1.57% |
Zymeworks Inc | ZYME | 1.55% |
Vertex Pharmaceuticals Inc | VRTX | 1.53% |
Amgen Inc | AMGN | 1.53% |
Rhythm Pharmaceuticals Inc | RYTM | 1.53% |
Insmed Inc | INSM | 1.52% |
Gilead Sciences Inc | GILD | 1.46% |
CRISPR Therapeutics AG | CRSP | 1.46% |
Tarsus Pharmaceuticals Inc | TARS | 1.46% |
BioMarin Pharmaceutical Inc | BMRN | 1.45% |
Roivant Sciences Ltd | ROIV | 1.45% |
Bridgebio Pharma Inc | BBIO | 1.44% |
Incyte Corp | INCY | 1.44% |
Arrowhead Pharmaceuticals Inc | ARWR | 1.43% |
Harmony Biosciences Holdings Inc | HRMY | 1.43% |
ADMA Biologics Inc | ADMA | 1.43% |
ASCENDIS PHARMA A/S | ASCENDIS.PHARMA.A.S | 1.43% |
ImmunityBio Inc | IBRX | 1.43% |
Ironwood Pharmaceuticals Inc | IRWD | 1.42% |
Agios Pharmaceuticals Inc | AGIO | 1.42% |
BioCryst Pharmaceuticals Inc | BCRX | 1.42% |
BioNTech SE | BNTX | 1.42% |
Madrigal Pharmaceuticals Inc | MDGL | 1.4% |
Denali Therapeutics Inc | DNLI | 1.39% |
Krystal Biotech Inc | KRYS | 1.39% |
Ligand Pharmaceuticals Inc | LGND | 1.38% |
Biogen Inc | BIIB | 1.37% |
TG Therapeutics Inc | TGTX | 1.37% |
Syndax Pharmaceuticals Inc | SNDX | 1.35% |
Ultragenyx Pharmaceutical Inc | RARE | 1.32% |
Novavax Inc | NVAX | 1.31% |
Aurinia Pharmaceuticals Inc | AUPH | 1.3% |
Cytokinetics Inc | CYTK | 1.29% |
Exelixis Inc | EXEL | 1.29% |
Theravance Biopharma Inc | TBPH | 1.29% |
Mirum Pharmaceuticals Inc | MIRM | 1.23% |
Arcutis Biotherapeutics Inc | ARQT | 1.23% |
Neurocrine Biosciences Inc | NBIX | 1.21% |
Liquidia Corp | LQDA | 1.2% |
United Therapeutics Corp | UTHR | 1.19% |
PTC Therapeutics Inc | PTCT | 1.17% |
Phathom Pharmaceuticals Inc | PHAT | 1.11% |
Alnylam Pharmaceuticals Inc | ALNY | 1.06% |
Ionis Pharmaceuticals Inc | IONS | 1.05% |
Axsome Therapeutics Inc | AXSM | 0.98% |
Ardelyx Inc | ARDX | 0.84% |
Legend Biotech Corp | LEGN | 0.7% |
Cash/Cash equivalents | Cash.Cash.equivalents | 0.21% |
OmniAb Inc | OmniAb.Inc | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Virtus LifeSci Biotech Products ETF (BBP) share price today is $106.46.
Yes, Indians can buy shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. To buy BBP from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. You can start investing in Virtus LifeSci Biotech Products ETF (BBP) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Products ETF (BBP) is $110.05. The 52-week low price of Virtus LifeSci Biotech Products ETF (BBP) is $68.05.
The stock symbol (or ticker) of Virtus LifeSci Biotech Products ETF is BBP.
Yes, you can setup SIP in Virtus LifeSci Biotech Products ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBP on the Vested app.
The expense ratio of Virtus LifeSci Biotech Products ETF (BBP) is 0.79%.
Link copied